Madeline McCrary
banner
madelinemc5.bsky.social
Madeline McCrary
@madelinemc5.bsky.social
ID & Addiction Med physician and OPAT @WashUID via @UNC_ID & @christianacare | dog, pun and live music enthusiast
Reposted by Madeline McCrary
Hot off the press! Our experience in providing HCV meds in-hand to postpartum women at discharge from hospital admissions for labor and delivery.

Meds to beds = higher HCV treatment completion than a traditional linkage to outpatient care-based approach.

journals.lww.com/ogopen/fullt...
journals.lww.com
September 11, 2025 at 10:40 PM
Reposted by Madeline McCrary
@madelinemc5.bsky.social and I are excited to share that our HCV rapid start program at WashU ID has delivered over 200 courses of HCV meds to the bedside for inpatients at BJH! This allows people to start HCV rx at discharge, just like they would for any other new med prescribed on discharge.
June 16, 2025 at 11:06 PM
Reposted by Madeline McCrary
Emergence of infective endocarditis due to Serratia spp.: Results of a multicenter cohort

✅ Just Accepted
#IDSky
Emergence of infective endocarditis due to Serratia spp.: Results of a multicenter cohort
Infective endocarditis due to Serratia spp. (S-IE) has historically been considered a rare entity. Typically linked to injection drug use (IDU), S-IE appears to be a growing problem as the harms of unsafe drug use proliferate. However, guidance on therapy for gram-negative IE remains limited.
buff.ly
January 30, 2025 at 7:44 PM
Serratia IE - an emerging infection among PWID in midst of rising IDU in US.
- high mortality
- unclear mgmt
- biofilms?!
- more research/registry needed!

@asherjs.bsky.social

academic.oup.com/ofid/advance...
Emergence of infective endocarditis due to Serratia spp.: Results of a multicenter cohort
Serratia spp. infective endocarditis (S-IE) is described as a rare entity associated with injection drug use (IDU). However, in a cohort of 4 US health sys
academic.oup.com
January 23, 2025 at 7:57 PM
Reposted by Madeline McCrary